Author | Guru Sonpavde, MD | OncLive

Author | Guru Sonpavde, MD

Articles

Dr. Sonpavde on the Potential for Neoadjuvant Immunotherapy in Bladder Cancer

June 07, 2019

Video

Guru P. Sonpavde, MD, director of Bladder Cancer at Dana-Farber Cancer Institute, discusses the potential for neoadjuvant immunotherapy in bladder cancer.

Dr. Sonpavde on Accelerated Approval of Erdafitinib in Bladder Cancer

May 03, 2019

Video

Guru Sonpavde, MD, director of Bladder Cancer at Dana-Farber Cancer Institute, discusses the FDA accelerated approval of erdafitinib (Balversa) in bladder cancer.

Dr. Sonpavde on the Role of Durvalumab in Platinum-Refractory Bladder Cancer

April 24, 2019

Video

Guru Sonpavde, MD, director of Bladder Cancer at Dana-Farber Cancer Institute, discusses the role of durvalumab in the treatment of patients with platinum-refractory bladder cancer.

Dr. Sonpavde on Remaining Questions With Immunotherapy in Bladder Cancer

September 19, 2018

Video

Guru Sonpavde, MD, director of Bladder Cancer at Dana-Farber Cancer Institute, discusses remaining questions with immunotherapy in bladder cancer.

x